Compare
Nuo Therapeutics, Inc. vs OSR Health, Inc. vs Tenon Medical, Inc. vs QHSLab, Inc.
| Latest fiscal year | Nuo Therapeutics, Inc. AURX | OSR Health, Inc. OSRH | Tenon Medical, Inc. TNON | QHSLab, Inc. USAQ |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $3.31M | $2.91M | $3.94M | $2.69M |
| Revenue growth (YoY) | +142.7% | -17.7% | +20.4% | +26.3% |
| Gross margin | 66.9% | 20.4% | 59.8% | 67.3% |
| Operating margin | -76.0% | -631.0% | -324.3% | 4.9% |
| Net margin | -75.8% | -931.2% | -318.4% | 17.0% |
| Net income | -$2.51M | -$27.06M | -$12.56M | $457.4K |
| EPS (Diluted) | n/a | -$0.80 | -$1.70 | $0.02 |
| Operating cash flow | -$865.0K | -$4.33M | -$10.74M | $178.1K |
| Free cash flow | -$1.14M | n/a | -$11.02M | n/a |
| Cash & equivalents | $548.9K | $1.70M | $3.76M | $636.2K |
| Total assets | $1.85M | $171.24M | $10.76M | $2.17M |
| Total liabilities | $2.80M | $44.20M | $5.72M | $546.1K |
| Shareholders' equity | -$956.6K | $127.04M | $5.04M | $1.62M |
| Return on year-end equity | n/a | -21.3% | -249.1% | 28.1% |
| Shares outstanding | 48.18M | 26.60M | 10.85M | 15.03M |
Revenue, most recent five fiscal years
| Fiscal year | Nuo Therapeutics, Inc. | OSR Health, Inc. | Tenon Medical, Inc. | QHSLab, Inc. |
|---|---|---|---|---|
| Latest | $3.31M Ended 2025-12-31 | $2.91M Ended 2025-12-31 | $3.94M Ended 2025-12-31 | $2.69M Ended 2025-12-31 |
| 1 year earlier | $1.37M Ended 2024-12-31 | $3.53M Ended 2024-12-31 | $3.28M Ended 2024-12-31 | $2.13M Ended 2024-12-31 |
| 2 years earlier | $608.5K Ended 2023-12-31 | n/a | $2.93M Ended 2023-12-31 | $1.41M Ended 2023-12-31 |
| 3 years earlier | $112.2K Ended 2022-12-31 | n/a | $691.0K Ended 2022-12-31 | $1.24M Ended 2022-12-31 |
| 4 years earlier | $0 Ended 2021-12-31 | n/a | $160.0K Ended 2021-12-31 | $1.41M Ended 2021-12-31 |